National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
VINCRISTINE SULFATE INJECTION , US
Definition:
Reference/Part Number
Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
---|---|---|---|---|---|---|---|---|
NDC00002-7199-09 | 75602 | A | 3 | 2 | 6 | 54 | ||
ONCOVIN | 75602 | A | 5 | 1 | 4 | KX |
CAGE Information
Code | Company |
---|---|
75602 | ELI LILLY AND COMPANY |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
MRC | Requirements Statement | Clear Text Reply |
---|---|---|
AJCN | PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER |
SUPP | SUPPLEMENTARY FEATURES | ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 3 |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | VINCRISTINE SULFATE INJECTION USP 2ML SYRINGE 3S |
CQCT | PRIMARY CONTAINER TYPE | SYRINGE |